2012, ISBN: 9783642803666
[ED: Softcover], [PU: Springer / Springer Berlin Heidelberg / Springer, Berlin], It has been over 30 years since the first clinically important member of the quinolone class, nalidixic ac… Mehr…
booklooker.de buecher.de GmbH & Co. KG Versandkosten:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
2012, ISBN: 3642803660
[EAN: 9783642803666], Neubuch, [SC: 0.0], [PU: Springer Berlin Heidelberg], CHINOLON(GYRASEHEMMER); DNA; FLUORCHINOLON; QUINOLONES; SEPSIS; QUINOLONEANTIBACTERIALS, Druck auf Anfrage Neuw… Mehr…
ZVAB.com AHA-BUCH GmbH, Einbeck, Germany [51283250] [Rating: 5 (von 5)] NEW BOOK. Versandkosten:Versandkostenfrei. (EUR 0.00) Details... |
ISBN: 9783642803666
It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical practice. The modification produced in the quinol… Mehr…
BarnesandNoble.com new in stock. Versandkosten:zzgl. Versandkosten. Details... |
Quinolone Antibacterials / Jochen Kuhlmann (u. a.) / Taschenbuch / Handbook of Experimental Pharmacology / Paperback / XVIII / Englisch / 2012 / Springer-Verlag GmbH / EAN 9783642803666 - Taschenbuch
2012, ISBN: 9783642803666
[ED: Taschenbuch], [PU: Springer-Verlag GmbH], It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical pr… Mehr…
booklooker.de |
Quinolone Antibacterials | Jochen Kuhlmann (u. a.) | Taschenbuch | Handbook of Experimental Pharmacology | Paperback | XVIII | Englisch | 2012 | Springer-Verlag GmbH | EAN 9783642803666 - Taschenbuch
2012, ISBN: 9783642803666
[ED: Taschenbuch], [PU: Springer-Verlag GmbH], It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical pr… Mehr…
booklooker.de |
2012, ISBN: 9783642803666
[ED: Softcover], [PU: Springer / Springer Berlin Heidelberg / Springer, Berlin], It has been over 30 years since the first clinically important member of the quinolone class, nalidixic ac… Mehr…
2012, ISBN: 3642803660
[EAN: 9783642803666], Neubuch, [SC: 0.0], [PU: Springer Berlin Heidelberg], CHINOLON(GYRASEHEMMER); DNA; FLUORCHINOLON; QUINOLONES; SEPSIS; QUINOLONEANTIBACTERIALS, Druck auf Anfrage Neuw… Mehr…
ISBN: 9783642803666
It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical practice. The modification produced in the quinol… Mehr…
Quinolone Antibacterials / Jochen Kuhlmann (u. a.) / Taschenbuch / Handbook of Experimental Pharmacology / Paperback / XVIII / Englisch / 2012 / Springer-Verlag GmbH / EAN 9783642803666 - Taschenbuch
2012, ISBN: 9783642803666
[ED: Taschenbuch], [PU: Springer-Verlag GmbH], It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical pr… Mehr…
Quinolone Antibacterials | Jochen Kuhlmann (u. a.) | Taschenbuch | Handbook of Experimental Pharmacology | Paperback | XVIII | Englisch | 2012 | Springer-Verlag GmbH | EAN 9783642803666 - Taschenbuch
2012, ISBN: 9783642803666
[ED: Taschenbuch], [PU: Springer-Verlag GmbH], It has been over 30 years since the first clinically important member of the quinolone class, nalidixic acid, was introduced into medical pr… Mehr…
Bibliographische Daten des bestpassenden Buches
Autor: | |
Titel: | |
ISBN-Nummer: |
Detailangaben zum Buch - Quinolone Antibacterials Jochen Kuhlmann Editor
EAN (ISBN-13): 9783642803666
ISBN (ISBN-10): 3642803660
Taschenbuch
Erscheinungsjahr: 2012
Herausgeber: Springer Berlin Heidelberg Core >1 >T
Buch in der Datenbank seit 2012-09-20T10:43:03+02:00 (Berlin)
Detailseite zuletzt geändert am 2024-03-20T09:06:11+01:00 (Berlin)
ISBN/EAN: 9783642803666
ISBN - alternative Schreibweisen:
3-642-80366-0, 978-3-642-80366-6
Alternative Schreibweisen und verwandte Suchbegriffe:
Autor des Buches: kuhlmann, kuhl, zeiler, kühlmann, dalhoff
Titel des Buches: quinolone, quin, handbook experimental pharmacology
Daten vom Verlag:
Autor/in: Jochen Kuhlmann; A. Dalhoff; H.-J. Zeiler
Titel: Handbook of Experimental Pharmacology; Quinolone Antibacterials
Verlag: Springer; Springer Berlin
491 Seiten
Erscheinungsjahr: 2012-02-12
Berlin; Heidelberg; DE
Gedruckt / Hergestellt in Niederlande.
Sprache: Englisch
106,99 € (DE)
109,99 € (AT)
118,00 CHF (CH)
POD
XVIII, 491 p.
BC; Hardcover, Softcover / Medizin/Pharmazie; Pharmakologie; Verstehen; Chinolon (Gyrasehemmer); DNA; Fluorchinolon; Quinolones; Sepsis; quinolone antibacterials; Pharmacology; Biochemistry; Microbiology; Internal Medicine; Biochemie; Mikrobiologie (nicht-medizinisch); Klinische und Innere Medizin; BB
1 History and Introduction.- A. Chemistry.- B. Antibacterial Activity.- C. Oxygen and 4-Quinolones.- D. 4-Quinolone Kinetics and Distribution in Humans.- E. Outlook.- References.- 2 The Chemistry of the Quinolones: Methods of Synthesizing the Quinolone Ring System.- A. Introduction.- B. Methods of Synthesizing the Quinolone Ring System.- References.- 3 The Chemistry of the Quinolones: Chemistry in the Periphery of the Quinolones.- A. Introduction.- B. 1-Position.- C. 2-Position.- D. 3-Position.- E. 4-Position.- F. 5-Position.- G. 6-Position.- H. 7-Position.- I. 8-Position.- References.- 4 Mode of Action.- A. Introduction.- B. Effects on Bacteria.- C. Effects on DNA Gyrase.- D. Mode of Binding.- E. Mechanism of Cell Killing.- F. Conclusions and Future Prospects.- References.- 5 The In Vitro Antibacterial Activity of Quinolones: A Review.- A. Introduction.- B. In Vitro Activity.- C. The Future.- References.- 6 Pharmacokinetics of Fluoroquinolones in Experimental Animals.- A. Introduction.- B. Norfloxacin.- C. Pefloxacin.- D. Enoxacin.- E. Ofloxacin.- F. Ciprofloxacin.- G. Temafloxacin.- H. Tosufloxacin.- I. Fleroxacin.- J. Lomefloxacin.- K. Sparfloxacin.- L. Penetration of Quinolones at Sites of Infection.- References.- 7 Pharmacodynamics of Fluoroquinolones in Experimental Animals.- A. Introduction.- B. Bacterial Killing In Vivo.- C. In Vivo Postantibiotic Effects.- D. Pharmacodynamic Parameters Determining Efficacy.- E. Emergence of Resistance to Fluoroquinolones.- References.- 8 Interaction of Quinolones with Host-Parasite Relationship.- A. Introduction.- B. Effect on Adherence.- C. Effect Against Slowly Growing Bacteria.- D. Effect on Exoenzyme Production.- E. Quinolone-Induced Endotoxin Release.- F. Summary.- References.- 9 Mechanisms of Resistance to Fluoroquinolones.- A. Introduction.- B. Target Site Modification.- C. Reduced Intracellular Accumulation.- D. Reduced Killing.- E. Prevalence of Fluoroquinolone Resistance.- F. Distribution of Resistance Mechanisms.- G. Summary.- References.- 10 Toxicology and Safety Pharmacology of Quinolones.- A. Introduction.- B. Arthropathy.- C. Achilles Tendinitis and Rupture.- D. Nephropathy.- E. Effects on Central Nervous System.- F. Ocular Toxicity.- G. Impairment of Spermatogenesis.- H. Cardiovascular Effects.- I. Possible Mutagenic and Carcinogenic Effects.- J. Phototoxicity.- K. Photocarcinogenicity and Photomutagenicity.- L. Drug Interactions.- M. Metabolic and Nutritional Effects.- N. Conclusion.- References.- 11 Clinical Pharmacology.- A. Introduction.- B. Pharmacokinetics of Fluoroquinolone Antibiotics.- C. Interactions of Fluoroquinolone Antibiotics with Other Drugs.- D. Adverse Reactions of Fluoroquinolones.- References.- 12 Concentration-Effect Relationship of the Fluoroquinolones.- A. Introduction.- B. Pharmacodynamic Data of Antimicrobials as a Basis for Clinical Use.- C. Pharmacokinetic Aspects.- D. Summary and Conclusion.- References.- 13 Clinical Use of Quinolones.- A. Introduction.- B. Urinary Tract Infections and Prostatitis.- C. Gastrointestinal Infections and Traveller’s Diarrhea.- D. Respiratory Tract Infections.- E. Osteomyelitis.- F. Skin and Skin Structure Infection.- G. Sexually Transmitted Diseases.- H. Intra-abdominal Infections.- I. Bacteremia and Sepsis.- J. Surgical Prophylaxis.- K. Infections in Neutropenic Patients.- L. Use of Quinolones in Pediatrics.- M. Remarks.- References.- 14 Future Aspects.- A. Introduction.- B. Molecular Structure and Mechanism of Action.- C. Antimicrobial Activity.- D. Bacterial Resistance.- E. Future Use of Quinolones in Pediatrics.-F. Antitumor Potential.- G. New Attitudes.- H. Directions of Future Research on the Quinolones.- References.Weitere, andere Bücher, die diesem Buch sehr ähnlich sein könnten:
Neuestes ähnliches Buch:
9783540625124 Quinolone Antibacterials (Handbook of Experimental Pharmacology, 127) (Jochen Kuhlmann, A. Dalhoff, H.-J. Zeiler)
< zum Archiv...